Vera Therapeutics (VERA) Insider Trading Activity 2025 - MarketBeat

4 days ago · View the latest VERA insider trading activity at MarketBeat. ... Vera Therapeutics (VERA) Insider Trading & Ownership $34.77-2.25 (-6.08%) ... (NASDAQ:VERA) was last …

08%
OFF

Vera Therapeutics (VERA) Insider Trading Activity 2025 - MarketBeat

1 week from now

4 days ago · View the latest VERA insider trading activity at MarketBeat. ... Vera Therapeutics (VERA) Insider Trading & Ownership $34.77-2.25 (-6.08%) ... (NASDAQ:VERA) was last …

marketbeat.com

$43.07
OFF

Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells ...

1 week from now

4 days ago · On Wednesday, December 18th, Marshall Fordyce sold 17,500 shares of Vera Therapeutics stock. The stock was sold at an average price of $43.07, for a total transaction of …

etfdailynews.com

3%
OFF

What's Going On With Vera Therapeutics Stock? - Benzinga

1 week from now

3 days ago · Vera Therapeutics Inc VERA shares are trading lower by 7.3% to $34.31 Monday afternoon. The company announced an exclusive license agreement with Stanford University …

benzinga.com

$753680
OFF

Vera Therapeutics Insider Sold Shares Worth $753,680, According …

1 week from now

Dec 20, 2024 · -- Marshall Fordyce, Director, President and CEO, on December 18, 2024, sold 17,500 shares in Vera Therapeutics for $753,680. Following the Form 4 filing with the SEC, …

marketscreener.com

3%
OFF

Vera Therapeutics (NASDAQ:VERA) Stock Price Down 7.3% After …

1 week from now

5 days ago · Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price dropped 7.3% on Friday following insider selling activity. The company traded as low as $39.01 and last …

modernreaders.com

$753725.00
OFF

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $753,725.00 In …

1 week from now

Dec 21, 2024 · Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CEO Marshall Fordyce sold 17,500 shares of the firm's stock in a transaction on Wednesday, December …

insidertrades.com

1%
OFF

Franklin Resources Inc. Sells 5,859 Shares Of Vera Therapeutics, Inc ...

1 week from now

Jan 1, 2025 · Franklin Resources Inc. lessened its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 40.1% during the 3rd quarter, according to its most recent …

etfdailynews.com

05%
OFF

Marker Therapeutics (MRKR) Insider Trading Activity 2025

1 week from now

Jan 10, 2025 · View the latest MRKR insider trading activity at MarketBeat. ... Marker Therapeutics (MRKR) Insider Trading & Ownership $2.83-0.03 (-1.05%) As of 01/10/2025 …

marketbeat.com

1%
OFF

Incyte Co. (NASDAQ:INCY) Shares Acquired By Contravisory

1 week from now

1 day ago · Contravisory Investment Management Inc. raised its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 50.1% in the fourth quarter, according to the company in its …

marketbeat.com

9%
OFF

Protagonist Therapeutics (NASDAQ:PTGX) Trading 8.9% Higher

1 week from now

1 day ago · Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) shares were up 8.9% during trading on Wednesday . The stock traded as high as $39.98 and last traded at …

marketbeat.com

FAQs about Vera Therapeutics (VERA) Insider Trading Activity 2025 - MarketBeat Coupon?

What happened to Vera Therapeutics shares?

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) gapped down prior to trading on Monday after an insider sold shares in the company. The stock had previously closed at $37.02, but opened at $35.00. Vera Therapeutics shares last traded at $32.05, with a volume of 160,823 shares trading hands. ...

How much is Vera Therapeutics stock worth?

Vera Therapeutics shares last traded at $32.05, with a volume of 160,823 shares trading hands. Specifically, CEO Marshall Fordyce sold 17,500 shares of Vera Therapeutics stock in a transaction dated Wednesday, January 8th. The stock was sold at an average price of $41.74, for a total transaction of $730,450.00. ...

What are Vera Therapeutics' share price objectives?

4 analysts have issued twelve-month price objectives for Vera Therapeutics' shares. Their VERA share price forecasts range from $6.00 to $38.00. On average, they predict the company's stock price to reach $15.75 in the next twelve months. This suggests a possible upside of 103.0% from the stock's current price. ...

Who owns Vera Therapeutics?

Mirae Asset Global Investments Co. Ltd. now owns 1,983 shares of the company’s stock worth $86,000 after acquiring an additional 350 shares in the last quarter. Public Employees Retirement Association of Colorado purchased a new stake in Vera Therapeutics in the second quarter worth $135,000. ...

How much does Vera Therapeutics make?

Vera Therapeutics (NASDAQ:VERA) has a market capitalization of $214.64 million. The company earns $-32,610,000.00 in net income (profit) each year or ($3.36) on an earnings per share basis. How can I contact Vera Therapeutics? ...

How many research reports have been made about Vera Therapeutics?

Vera Therapeutics has only been the subject of 3 research reports in the past 90 days. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. ...